MoonLake Immunotherapeutics (NASDAQ: MLTX)’s Post

For #Media #Investors MoonLake’s showcase of our cutting-edge #HSResearch continues today – don’t miss Dr Alexandra Charrow’s presentation that challenges assumptions about the prevalence of #HidradenitisSuppurativa, and check out our other posters on translational and clinical trial data. Want more details? Stop by the #SHSA2024 schedule of events: https://lnkd.in/eUbZpfmb #MLTX #HS #Nanobody #IL17A #IL17F

  • diagram

To view or add a comment, sign in

Explore topics